152 related articles for article (PubMed ID: 8403804)
1. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.
Markell MS; Altura BT; Barbour RL; Altura BM
Clin Sci (Lond); 1993 Sep; 85(3):315-8. PubMed ID: 8403804
[TBL] [Abstract][Full Text] [Related]
2. Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.
Allegra A; Corica F; Ientile R; Corsonello A; Sparacino V; Accettola F; Caputo F; Macaione S; Buemi M
Magnes Res; 1998 Mar; 11(1):11-8. PubMed ID: 9595545
[TBL] [Abstract][Full Text] [Related]
3. Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine.
Vannini SD; Mazzola BL; Rodoni L; Truttmann AC; Wermuth B; Bianchetti MG; Ferrari P
Transpl Int; 1999; 12(4):244-9. PubMed ID: 10460868
[TBL] [Abstract][Full Text] [Related]
4. Ionized and total serum magnesium concentrations in feline renal transplant recipients.
Wooldridge JD; Gregory CR
Vet Surg; 1999; 28(1):31-7. PubMed ID: 10025638
[TBL] [Abstract][Full Text] [Related]
5. Total cholesterol correlates with cyclosporine C2 levels in kidney transplant recipients under maintenance immunosuppression.
Cardinal H; Barama AA; Fradet V; Lallier M; Lévesque R; St Louis G; Hébert MJ; Girardin C; Pâquet M; Daloze P
Transplant Proc; 2004 Mar; 36(2 Suppl):448S-450S. PubMed ID: 15041384
[TBL] [Abstract][Full Text] [Related]
6. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients.
Nawaz SH; Zafar MN; Naqvi SA; Rizvi SA
J Pak Med Assoc; 2005 Mar; 55(3):98-100. PubMed ID: 15852743
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
[TBL] [Abstract][Full Text] [Related]
8. Long-term calcineurin inhibition and magnesium balance after renal transplantation.
Mazzola BL; Vannini SD; Truttmann AC; von Vigier RO; Wermuth B; Ferrari P; Bianchetti MG
Transpl Int; 2003 Feb; 16(2):76-81. PubMed ID: 12595968
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients.
Frost L; Danielsen H; Dørup I; Kjaer T; Pedersen EB
Nephrol Dial Transplant; 1993; 8(1):79-83. PubMed ID: 8381943
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
[TBL] [Abstract][Full Text] [Related]
11. Serum homocysteine levels in renal transplant recipients with and without hypercholesterolemia.
Piovesan F; Veronese FJ; Santos AF; Pozza R; Sarturi PS; Tognon A; Garcia VD; Keitel E; Saitovitch D
Arq Bras Cardiol; 2007 Sep; 89(3):154-9, 170-5. PubMed ID: 17906816
[TBL] [Abstract][Full Text] [Related]
12. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
[TBL] [Abstract][Full Text] [Related]
13. Renal functional reserve in cyclosporin-treated recipients of kidney transplant.
Ader JL; Tack I; Lloveras JJ; Tran-Van T; Rostaing L; Praddaude F; Durand D; Suc JM
Kidney Int; 1994 Jun; 45(6):1657-67. PubMed ID: 7933813
[TBL] [Abstract][Full Text] [Related]
14. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.
Dumoulin G; Hory B; Nguyen NU; Bresson C; Fournier V; Bouhaddi M; Chalopin JM; Saint-Hillier Y; Regnard J
Am J Kidney Dis; 1997 May; 29(5):746-53. PubMed ID: 9159310
[TBL] [Abstract][Full Text] [Related]
15. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H
Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283
[TBL] [Abstract][Full Text] [Related]
16. Calcium and phosphorus metabolism in stable renal transplant recipients.
Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
[TBL] [Abstract][Full Text] [Related]
17. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serum magnesium and blood cyclosporine A concentrations in renal transplant recipients.
Thakur V; Kumar R; Dhawan IK
Ann Clin Biochem; 2002 Jan; 39(Pt 1):70-2. PubMed ID: 11853195
[TBL] [Abstract][Full Text] [Related]
19. Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period.
Kavukçu S; Soylu A; Türkmen M; Kasap B; Gümüştekin M; Gülay H
Pediatr Nephrol; 2004 Jun; 19(6):667-71. PubMed ID: 15054646
[TBL] [Abstract][Full Text] [Related]
20. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
